Rapid reversal of coagulopathy using specific agents and blood pressure control are the mainstays of acute medical management for anticoagulant-associated intracerebral hemorrhage.
Acute management of anticoagulant-associated intracerebral hemorrhage relies on blood pressure control and rapid administration of specific reversal agents to prevent hematoma expansion.
Intracerebral hemorrhage (ICH) is the most dangerous complication of oral anticoagulant treatment (OAT). Up to half of patients with OAT-related ICH experience early clinical deterioration due to active bleeding, leading to hematoma enlargement. Prevention of ICH expansion is therefore one of the primary goals of acute ICH treatment. Blood pressure control and rapid reversal of coagulopathy are the mainstays of acute medical management. Specific reversal agents for vitamin K antagonists, direct thrombin inhibitors, and Factor Xa inhibitors are now available for clinical use, and may improve outcomes when given early enough in the clinical course.
Morotti et al. (Fri,) conducted a review in Anticoagulant-associated intracerebral hemorrhage. Blood pressure control and rapid reversal of coagulopathy was evaluated. Rapid reversal of coagulopathy using specific agents and blood pressure control are the mainstays of acute medical management for anticoagulant-associated intracerebral hemorrhage.